For its fourth fiscal quarter (ending December 31), Johnson & Johnson (NYSE: JNJ) has reported a -18% decline in E.P.S. from $1.71 a year ago to $1.41 in the current quarter. For the latest four quarters through December 31, E.P.S. were $5.79 compared to $5.26 a year ago — an increase of 10%.
Recent Price Action
Johnson & Johnson (NYSE: JNJ) stock closed at $145.27 on 1/22/25 after a modest decline of -1.9%. Moreover, unusually high trading volume at 195% of normal accompanied the decline. The stock has risen 0.6% during the last week and has performed in line with the market over the last nine months.
Current PriceTarget Research Rating
Johnson & Johnson has a current Value Trend Rating of D (Negative). This rating combines consistent signals from two proprietary PTR measures of a stock’s attractiveness. Johnson & Johnson has a neutral Power Rating of 42 and a slightly negative Appreciation Score of 31, producing the Negative Value Trend Rating.
Rating Review
In light of this new information we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment